Arrive AI Inc.

Listed Company

ARAICIK 0001818274NasdaqEmerging GrowthServices-To Dwellings & Other BuildingsDelawareFY ends Dec 31

Period

FY 2025

Revenue

$113.3K

Net Income

$-12.83M

Total Assets

$10.93M

Equity

$2.48M

Shares Out

47.73M

Op. Cash Flow

$-8.25M

Business

Arrive AI Inc. is a publicly listed company in To Dwellings & Other Buildings, incorporated in Delaware. Common stock trades on Nasdaq under the ticker ARAI.

Auto-generated from company profile

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31
REVENUE	113,250	—
General and administrative	10	4
Research and development	600,510	760,036
Sales and marketing	229,206	266,182
Total operating expenses	10	5
Interest expense	−686,897	−4,645
Other income	108,351	39,482
Change in fair value of derivative liabilities	2	—
Accretion of debt discount	−249,530	—
Loss on conversion of convertible notes payable	−3	—
Realized gain on investments	133,104	—
Total other income (expenses)	−2	34,837
NET LOSS BEFORE TAXES	−13	−5
PROVISION FOR INCOME TAXES	—	—
NET LOSS	−13	−5
Net loss per share: Basic	−0.4	−0.16
Net loss per share: Diluted	−0.4	−0.16
Weighted average common shares outstanding: Basic	32	29
Weighted average common shares outstanding: Diluted	32	29

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2025 2025-09-30	FY 2025 2025-06-30	FY 2024 2024-12-31	FY 2023 2023-12-31
Cash and cash equivalents	2	—	—	129,318	—
Accounts receivable	4,975	—	—	—	—
Prepaid expenses	189,878	—	—	55,867	—
Deferred offering costs	—	—	—	427,898	—
Other current assets	12,325	—	—	4,179	—
Total current assets	2	—	—	617,262	—
Property and equipment, net	514,684	—	—	95,425	—
Right of use assets - operating leases	2	—	—	—	—
Patents, net of accumulated amortization of $2,603 and $1,099	272,097	—	—	273,601	—
Deferred offering costs	6	—	—	—	—
Security deposits	65,633	—	—	1,500	—
Total other assets	9	—	—	370,526	—
TOTAL ASSETS	11	—	—	987,788	—
Accounts payable	183,993	—	—	2	—
Accrued expenses	538,234	—	—	83,192	—
Operating lease liability	392,950	—	—	—	—
Derivative liabilities	1	1	2	—	—
Convertible notes payable, net of discount and debt issuance costs of $3,379,447 and $240,896, respectively	4	—	—	—	—
Note payable	9,140	—	—	8,524	—
Total current liabilities	7	—	—	2	—
Operating lease liability	2	—	—	—	—
Note payable, net of current portion	1,418	—	—	10,558	—
Total long term liabilities	2	—	—	10,558	—
Total liabilities	8	—	—	2	—
Commitments and Contingencies (See Note 18)	—	—	—	—	—
Common stock, $0.0002 par value, 200,000,000 authorized, 34,213,387 and 29,120,905 issued and outstanding at December 31, 2025 and December 31, 2024	6,841	—	—	5,822	—
Additional paid-in capital	31	—	—	15	—
Subscription receivable	—	—	—	−53,003	—
Accumulated deficit	−29	—	—	−16	—
Total stockholders equity (deficit)	2	—	—	−983,175	−477,766
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	11	—	—	987,788	—

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31
Stock-based compensation	3	1
Depreciation and amortization	66,889	29,115
Impairment loss	10,541	—
Operating lease liability - non-cash adjustment	739	—
Accretion of discount on convertible notes payable	249,530	—
Accretion of issuance costs on convertible notes payable	332,160	—
Accounts receivable	−4,975	—
Prepaid expenses	−134,011	−46,724
Other current assets	−8,146	−4,179
Security deposits	−64,133	—
Accounts payable	−479,959	843,682
Accrued expenses	455,042	37,868
Net cash used in operating activities	−8	−2
Capital expenditures	−495,185	−38,155
Proceeds from sales of investments	10	—
Patent filing costs	—	−76,500
Purchase of investments	−10	—
Net cash used in investing activities	−362,081	−114,655
Proceeds from sale of common stock, net	448,057	3
Purchase of treasury stock	−74,743	—
Proceeds from the exercise of warrants, net	573,895	—
Repayments of note payables	−8,524	−7,954
Proceeds from issuance of convertible notes payable	11	—
Debt issuance costs	−660,000	—
Deferred offering costs	−688,570	−427,898
Net cash provided by financing activities	11	2
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	2	−196,154
Interest	67,555	1,635
Income taxes	—	—
Common stock issued as payment of offering costs	7	—
Common stock issued as settlement of legal expenses	1	—
Common stock issued for conversion of convertible notes payable	5	—
Derivative liabilities reclassified as additional paid-in capital upon conversion of convertible notes payable	2	—
Deferred offering costs reclassified as additional paid-in capital upon financing drawdown	2	—
Cashless exercise of stock options	6,164	—
Right-of-use assets obtained in exchange for lease obligations	2	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro